These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 12415554)

  • 21. Duloxetine in the treatment of Major Depressive Disorder: a comparison of efficacy in patients with and without melancholic features.
    Mallinckrodt CH; Watkin JG; Liu C; Wohlreich MM; Raskin J
    BMC Psychiatry; 2005 Jan; 5():1. PubMed ID: 15631624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-frequency repetitive transcranial magnetic stimulation improves refractory depression by influencing catecholamine and brain-derived neurotrophic factors.
    Yukimasa T; Yoshimura R; Tamagawa A; Uozumi T; Shinkai K; Ueda N; Tsuji S; Nakamura J
    Pharmacopsychiatry; 2006 Mar; 39(2):52-9. PubMed ID: 16555165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antidepressant efficacy of two different rTMS procedures. High frequency over left versus low frequency over right prefrontal cortex compared with sham stimulation.
    Höppner J; Schulz M; Irmisch G; Mau R; Schläfke D; Richter J
    Eur Arch Psychiatry Clin Neurosci; 2003 Apr; 253(2):103-9. PubMed ID: 12799750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Once-daily duloxetine 60 mg in the treatment of major depressive disorder: multicenter, double-blind, randomized, paroxetine-controlled, non-inferiority trial in China, Korea, Taiwan and Brazil.
    Lee P; Shu L; Xu X; Wang CY; Lee MS; Liu CY; Hong JP; Ruschel S; Raskin J; Colman SA; Harrison GA
    Psychiatry Clin Neurosci; 2007 Jun; 61(3):295-307. PubMed ID: 17472599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of rapid-rate transcranial magnetic stimulation (rTMS) in refractory depressed patients.
    Figiel GS; Epstein C; McDonald WM; Amazon-Leece J; Figiel L; Saldivia A; Glover S
    J Neuropsychiatry Clin Neurosci; 1998; 10(1):20-5. PubMed ID: 9547462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Depression associated with dementia with Lewy bodies (DLB) and the effect of somatotherapy.
    Takahashi S; Mizukami K; Yasuno F; Asada T
    Psychogeriatrics; 2009 Jun; 9(2):56-61. PubMed ID: 19604326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
    Fava M; McCall WV; Krystal A; Wessel T; Rubens R; Caron J; Amato D; Roth T
    Biol Psychiatry; 2006 Jun; 59(11):1052-60. PubMed ID: 16581036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repetitive transcranial magnetic stimulation: a putative add-on treatment for major depression in elderly patients.
    Mosimann UP; Schmitt W; Greenberg BD; Kosel M; Müri RM; Berkhoff M; Hess CW; Fisch HU; Schlaepfer TE
    Psychiatry Res; 2004 Apr; 126(2):123-33. PubMed ID: 15123391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing depression outcome in patients with moderate dementia: sensitivity of the HoNOS65+ scale.
    Canuto A; Rudhard-Thomazic V; Herrmann FR; Delaloye C; Giannakopoulos P; Weber K
    J Neurol Sci; 2009 Aug; 283(1-2):69-72. PubMed ID: 19261298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultra-brief pulse ECT in bipolar and unipolar depressive disorder: differences in speed of response.
    Sienaert P; Vansteelandt K; Demyttenaere K; Peuskens J
    Bipolar Disord; 2009 Jun; 11(4):418-24. PubMed ID: 19500095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
    Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
    J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Self-rating scales in schizophrenia: assessment of the practical applicability of the Paranoid-Depression Scale (PD-S), the Frankfurt Self-feeling Scale (FBS) and of two visual analogue scales].
    Schaeffer E; Wciórka J
    Psychiatr Pol; 2003; 37(2):315-35. PubMed ID: 12776661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Motor cortical excitability and clinical response to rTMS in depression.
    Fitzgerald PB; Brown TL; Marston NA; Daskalakis ZJ; de Castella A; Bradshaw JL; Kulkarni J
    J Affect Disord; 2004 Oct; 82(1):71-6. PubMed ID: 15465578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical effect of nemifitide, a novel pentapeptide antidepressant, in the treatment of severely depressed refractory patients.
    Feighner JP; Sverdlov L; Hlavka J; Nicolau G; Cartwright K; Freed JS
    Int Clin Psychopharmacol; 2008 Jan; 23(1):29-35. PubMed ID: 18090505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of a series of repetitive transcranial magnetic stimulations of the motor cortex on central pain after spinal cord injury.
    Defrin R; Grunhaus L; Zamir D; Zeilig G
    Arch Phys Med Rehabil; 2007 Dec; 88(12):1574-80. PubMed ID: 18047871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of unilateral repetitive transcranial magnetic stimulation of the motor cortex on chronic widespread pain in fibromyalgia.
    Passard A; Attal N; Benadhira R; Brasseur L; Saba G; Sichere P; Perrot S; Januel D; Bouhassira D
    Brain; 2007 Oct; 130(Pt 10):2661-70. PubMed ID: 17872930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of electroconvulsive therapy in repetitive transcranial magnetic stimulation non-responder MDD patients: a preliminary study.
    Dannon PN; Grunhaus L
    Int J Neuropsychopharmacol; 2001 Sep; 4(3):265-8. PubMed ID: 11602032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A controlled trial of daily left prefrontal cortex TMS for treating depression.
    George MS; Nahas Z; Molloy M; Speer AM; Oliver NC; Li XB; Arana GW; Risch SC; Ballenger JC
    Biol Psychiatry; 2000 Nov; 48(10):962-70. PubMed ID: 11082469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjunctive bright light in non-seasonal major depression: results from clinician-rated depression scales.
    Martiny K; Lunde M; Undén M; Dam H; Bech P
    Acta Psychiatr Scand; 2005 Aug; 112(2):117-25. PubMed ID: 15992393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.